Clinical Trial

Stimulating the Cochlear Apex Without Longer Electrodes

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The most common cochlear implant intervention provides an electrode array that stimulates less than half of the length of the cochlea, leaving the regions which represent lower frequencies in the normally functioning ear unstimulated. Providing stimulation over the entire cochlea has the potential to improve speech understanding, sound quality, as well as spectral and temporal representation. Increasing the length of the electrode array to cover a greater portion of the cochlea has many potential issues, including increased damage to the cochlea and probability of incomplete insertions. In this study, a new technique is being investigated that allows stimulation across the entire cochlear extent without increasing the length of the electrode array. The purpose of this study is to evaluate the benefit of the new technique on speech understanding outcomes. Additionally, the study will investigate the new configuration to explore how the auditory system encodes temporal and spectral information.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-24; most recent amendment 2026-03-04.
Status change: Recruiting → Active, Not Recruiting 2026-02-10
Trial Details
NCT Number NCT06901674
Lead Sponsor NYU Langone Health
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions Deafness With a Cochlear Implant
Enrollment 40 participants
Start Date 2022-08-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-06